Patent details

Basic Information

Publication number:

EP2195462

PCT Application Number:

PCT/US/2008/076147

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088302096

PCT Publication Number:

WO/2009/036257

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PREDICTION OF SLEEP PARAMETER AND RESPONSE TO SLEEP-INDUCING COMPOUND BASED ON PER3 VNTR GENOTYPE

French Title of Invention:

PRÉVISION D'UN PARAMÈTRE DU SOMMEIL ET DE LA RÉPONSE À UN COMPOSÉ INDUISANT LE SOMMEIL À BASE DU GÉNOTYPE DU MINISATELLITE (VNTR) PER3

German Title of Invention:

PROGNOSE VON SCHLAFPARAMETERN UND REAKTIONEN AUF EINE SCHLAFFÖRDERNDE VERBINDUNG AUF BASIS DES GENOTYPS PER3 VNTR

SPC Number:

Dates

Filing date:

12/09/2008

Grant date:

12/06/2013

EP Publication Date:

12/06/2013

PCT Publication Date:

19/03/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/06/2010

EP B1 Publication Date:

12/06/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/09/2013

Expiration date:

12/09/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/09/2008

 

 

Name:

Vanda Pharmaceuticals Inc.

Address:

9605 Medical Center Drive, Suite 300, Rockville, MD 20850, United States (US)

Inventor

1

Name:

LAVEDAN Christian

Address:

United States (US)

2

Name:

BIRZNIEKS Gunther

Address:

United States (US)

3

Name:

POLYMEROPOULOS Mihael H.

Address:

United States (US)

Priority

Priority Number:

972196 P

Priority Date:

13/09/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C12Q 1/68;

Filing date	Document type	Number of pages